AbbVie Inc. (4AB.DE)

EUR 168.02

(0.36%)

Long Term Debt Summary of AbbVie Inc.

  • AbbVie Inc.'s latest annual long term debt in 2023 was 52.19 Billion USD , down -11.74% from previous year.
  • AbbVie Inc.'s latest quarterly long term debt in 2024 Q2 was 58.04 Billion USD , down -9.06% from previous quarter.
  • AbbVie Inc. reported annual long term debt of 59.13 Billion USD in 2022, down -7.87% from previous year.
  • AbbVie Inc. reported annual long term debt of 64.18 Billion USD in 2021, down -17.23% from previous year.
  • AbbVie Inc. reported quarterly long term debt of 58.04 Billion USD for 2024 Q2, down -9.06% from previous quarter.
  • AbbVie Inc. reported quarterly long term debt of 55.63 Billion USD for 2023 Q3, down -0.32% from previous quarter.

Annual Long Term Debt Chart of AbbVie Inc. (2023 - 2010)

Historical Annual Long Term Debt of AbbVie Inc. (2023 - 2010)

Year Long Term Debt Long Term Debt Growth
2023 52.19 Billion USD -11.74%
2022 59.13 Billion USD -7.87%
2021 64.18 Billion USD -17.23%
2020 77.55 Billion USD 23.15%
2019 62.97 Billion USD 79.92%
2018 35 Billion USD 13.08%
2017 30.95 Billion USD -15.06%
2016 36.44 Billion USD 24.62%
2015 29.24 Billion USD 176.76%
2014 10.56 Billion USD -26.08%
2013 14.29 Billion USD -2.31%
2012 14.63 Billion USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%

Peer Long Term Debt Comparison of AbbVie Inc.

Name Long Term Debt Long Term Debt Difference
Bayer Aktiengesellschaft 37.23 Billion EUR -40.186%
Sanofi 14.34 Billion EUR -263.797%